Johnson & Johnson Plans $55B US Investment Over Four Years

Johnson & Johnson has announced a significant investment of over $55 billion in the United States over the next four years, marking a 25% increase from previous years. This initiative includes the groundbreaking of a $2 billion biologics manufacturing facility in Wilson, North Carolina, which is expected to create thousands of jobs and generate a substantial economic impact in the region. The investment will also support the establishment of three additional advanced manufacturing facilities and enhance research and development in areas like oncology and neuroscience. J&J's CEO, Joaquin Duato, emphasized the company's commitment to American innovation and its role in addressing healthcare challenges. This move aligns with the broader trend of U.S. companies increasing domestic investments, influenced by the 2017 Tax Cuts & Jobs Act and ongoing tariff threats from the Trump administration. The company's efforts are anticipated to contribute more than $100 billion annually to the U.S. economy.